首页> 外文期刊>American journal of therapeutics >Treatment resistant hypertension.
【24h】

Treatment resistant hypertension.

机译:治疗抗性高血压。

获取原文
获取原文并翻译 | 示例
           

摘要

Treatment resistant hypertension is defined as a blood pressure not achieving a goal blood pressure (<140/90 mm Hg) with a combination of three or more antihypertensive drugs. There are several causes for patients not responding to antihypertensive medication. One of the major reasons is noncompliance to the treatment, often because of real or perceived side effects or because of a great number of medications and frequent dosing. Exogenous substances, most frequently nonsteroidal anti-inflammatory drugs, and, often not recognized, over-the-counter medications containing ephedrine or pseudo-ephedrine, can reduce the effect of antihypertensive drugs. Obesity and obstructive sleep apnea oppose antihypertensive drug effects by several mechanisms but predominantly by an increase in the activity of the sympathetic and renin-angiotensin-aldosterone systems. White coat hypertension as a cause of treatment resistance is suspected if there is no target organ damage or if the patients complain of symptoms of hypotension during antihypertensive treatment. Secondary forms of hypertension, although comprising only approximately 5% of patients with treatment resistant hypertension, are important to identify because they may represent a curable form of hypertension.
机译:抗治疗性高血压定义为通过三种或更多种降压药的组合无法达到目标血压(<140/90 mm Hg)的血压。导致患者对降压药无效的原因有多种。主要的原因之一是不服从治疗,通常是由于真实或可察觉的副作用,或者是由于大量药物和频繁给药。外源性物质(最常见的是非甾体抗炎药),以及常常不被认可的含有麻黄碱或伪麻黄碱的非处方药,可能会降低降压药的作用。肥胖和阻塞性睡眠呼吸暂停通过几种机制来对抗降压药的作用,但主要是通过增加交感神经系统和肾素-血管紧张素-醛固酮系统的活性。如果没有靶器官损害或患者在降压治疗期间抱怨出现低血压症状,则怀疑白大衣高血压是引起治疗抵抗的原因。继发性高血压虽然仅占治疗性高血压患者的约5%,但由于其可能代表可治愈的高血压形式,因此对其进行识别非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号